To describe the clinical characteristics of patients infected with the Omicron variant of COVID-19, particularly regarding organ dysfunction, and to identify risk factors for severe cases and mortality compared to the Wild-type strain, with a focus on differences in organ dysfunction patterns.
Key Findings:
Omicron variant associated with lower hospitalization and mortality rates compared to Wild-type strain, indicating a shift in clinical outcomes.
Significant differences in organ dysfunction patterns observed between Omicron and Wild-type cohorts, suggesting variant-specific clinical management may be necessary.
Increased incidence of severe cases during the Omicron outbreak despite its lower virulence, highlighting the need for targeted healthcare responses.
Interpretation:
The Omicron variant, while less virulent, led to a surge in severe COVID-19 cases, underscoring the need for ongoing monitoring of organ dysfunction and patient outcomes to inform public health strategies.
Limitations:
Retrospective design may introduce bias.
Data collection limited to specific timeframes and centers.
Potential confounding factors may affect the interpretation of results.
Conclusion:
The study underscores the importance of understanding organ failure patterns in COVID-19 variants to inform clinical management and resource allocation during outbreaks.
